The Jett Foundation Fighting Duchenne Muscular Dystrophy

Join us to make Duchenne History

December 17, 2015

1b5dc147-3ee6-4394-904b-cc13fb1c7030

Today, the FDA announced that on January 22, 2016, an FDA Advisory Committee will convene to review eteplirsen, a very promising treatment for Duchenne that has shown strong evidence of safety and efficacy. During that meeting, it is critical that the Advisory Committee hear from all of us – the Duchenne community.

Please mark your calendars!  We will be in touch with more details soon.

TAKE A STAND. FILL A SEAT. RAISE YOUR VOICE.

January 22, 2016 | Silver Spring, MD

Show Buttons
Hide Buttons